Cargando…

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening

BACKGROUND: Colonoscopy surveillance intervals are based on the predicted risk of metachronous colorectal cancer (CRC) after polyp removal. However, risk estimation per polyp subtype is difficult due to the fact that many patients have multiple polyps. To enable risk estimation per polyp subtypes we...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Toledo, D.E.F.W.M., IJspeert, J.E.G., Spaander, M.C.W., Nagtegaal, I.D., van Leerdam, M.E., Lansdorp-Vogelaar, I., Dekker, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388570/ https://www.ncbi.nlm.nih.gov/pubmed/37528844 http://dx.doi.org/10.1016/j.eclinm.2023.102066

Ejemplares similares

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
por: Kooyker, Arthur I., et al.
Publicado: (2020)

Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
por: van de Schootbrugge-Vandermeer, Hilliene J., et al.
Publicado: (2023)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2022)

Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
por: Nieuwenburg, S. A. V., et al.
Publicado: (2021)

Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
por: van der Vlugt, Manon, et al.
Publicado: (2017)

Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing
por: van der Meulen, Miriam P., et al.
Publicado: (2022)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

Smoking status informs about the risk of advanced serrated polyps in a screening population
por: IJspeert, J. E. G., et al.
Publicado: (2016)

Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2019)

Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas
por: van der Vlugt, Manon, et al.
Publicado: (2022)

Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic
por: de Jonge, Lucie, et al.
Publicado: (2022)

Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT)
por: Breekveldt, Emilie C. H., et al.
Publicado: (2023)

Detection of Colorectal Serrated Polyps by Stool DNA Testing: Comparison with Fecal Immunochemical Testing for Occult Blood (FIT)
por: Heigh, Russell I., et al.
Publicado: (2014)

Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT‐based CRC screening program
por: Breekveldt, Emilie C. H., et al.
Publicado: (2022)

The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic
por: Kortlever, Tim L., et al.
Publicado: (2021)

A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic
por: de Klerk, Clasine M, et al.
Publicado: (2017)

Substantial and sustained improvement of serrated polyp detection after a simple educational intervention: results from a prospective controlled trial
por: Bleijenberg, Arne G C, et al.
Publicado: (2020)

Polyps and Colorectal Cancer in Serrated Polyposis Syndrome: Contribution of the Classical Adenoma-Carcinoma and Serrated Neoplasia Pathways
por: van Toledo, David E. F. W. M., et al.
Publicado: (2023)

Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2023)

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study
por: Buskermolen, Maaike, et al.
Publicado: (2019)

Which Fecal Immunochemical Test Should I Choose?
por: Daly, Jeanette M., et al.
Publicado: (2017)

Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model
por: Meester, Reinier G S, et al.
Publicado: (2023)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Management of large polyps in a colorectal cancer screening program with fecal immunochemical test: a community- and population-based observational study
por: Denis, Bernard, et al.
Publicado: (2021)

Profiling small RNAs in fecal immunochemical tests: is it possible?
por: Birkeland, Einar, et al.
Publicado: (2023)

Incidental diagnosis of serrated polyp in the appendix warrants colonoscopy to screen for colorectal neoplasia
por: van Herwaarden, Y J, et al.
Publicado: (2021)

Positive Fecal Immunochemical Test or Cologuard in the Era of the Novel Coronavirus Disease-2019 Pandemic
por: Young, Patrick E., et al.
Publicado: (2020)

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels
por: Hol, L, et al.
Publicado: (2009)

Interpretation and adherence to the updated risk-stratified guideline for colonoscopy surveillance after polypectomy – a nationwide survey
por: van der Meulen, Miriam P., et al.
Publicado: (2020)

Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program
por: Vleugels, Jasper L. A., et al.
Publicado: (2017)

Faecal immunochemical testing for haemoglobin in detecting bowel polyps in symptomatic patients: multicentre prospective cohort study
por: Bath, Michael F, et al.
Publicado: (2023)

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
por: Stegeman, Inge, et al.
Publicado: (2012)

Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
por: Baxter, Nielson T., et al.
Publicado: (2016)

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study
por: de Jonge, Lucie, et al.
Publicado: (2021)

Assessment of disease activity by fecal immunochemical test in ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2016)

Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
por: Kim, Nam Hee, et al.
Publicado: (2017)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Improving Adenoma Detection Rates: The Role of the Fecal Immunochemical Test
por: Nwankwo, Eugene C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gjqrak61qqhm05jjjik5v8a2u4